Related Experiment Video
Updated: Jan 11, 2026

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine
Published on: August 24, 2018
Massive Valproic Acid Overdose With Confirmed Pharmacobezoar Formation and Neuromuscular Toxicity: A Case Report and
Maryam K Alrazooqi1, Lara Abumuaileq1, Sania Zia1
1Emergency Medicine, Rashid Hospital Trauma Center, Dubai, ARE.
Abstract:
We present a 42-year-old man who arrived obtunded to our emergency department (ED) after ingesting 60 g of extended-release valproic acid (VPA). Imaging and endoscopy confirmed a pharmacobezoar, a rare complication of overdose.The patient was managed with early airway protection, gastrointestinal (GI) decontamination, intravenous (IV) levocarnitine (L-carnitine), naloxone, and continuous renal replacement therapy (CRRT). His initial hospital course was stable but later complicated by delayed neuromuscular toxicity with extrapyramidal symptoms (EPS) requiring inpatient rehabilitation and multidisciplinary follow-up. This case highlights the clinical challenge of massive VPA overdose complicated by pharmacobezoar formation and delayed neuromuscular sequelae. Early risk assessment led to recognition and aggressive treatment of a potentially life-threatening ingestion in which airway protection, serial monitoring, endoscopic confirmation, and extracorporeal elimination were crucial to a favorable outcome. This case underscores the need for vigilance in severe VPA ingestions and reinforces the role of advanced diagnostic and therapeutic strategies in preventing further deterioration.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Prevention of Further Absorption of Poison
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

